logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11433090 B1

PDFFull Text
Date of Patent:
Sep. 06, 2022

Filed:

Jun. 15, 2018

Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof

Applicant:

The Doshisha, Kyoto, JP;

Inventors:

Noriko Koizumi, Kyoto, JP;

Naoki Okumura, Kyoto, JP;

Assignee:

The Doshisha, Kyoto, JP;

Attorney:

Marshall, Gerstein & Borun LLP

Primary Examiner:

Sean McGarry

Int. Cl.
CPC ...
A61P 27/02 (2006.01); A61K 31/711 (2006.01); A61K 31/7105 (2006.01); A61K 31/436 (2006.01); C12Q 1/68 (2018.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/711 (2013.01); A61K 31/436 (2013.01); A61K 31/7105 (2013.01); A61P 27/02 (2018.01); A61K 45/06 (2013.01);
Abstract

The present invention provides a medicine and a method for preventing or treating ophthalmic symptoms, disorders, or diseases. The present invention provides an mTOR-inhibitor-containing composition for preventing or treating ophthalmic symptoms, disorders, or diseases. In some of the embodiments of the present invention, this composition is capable of treating or preventing corneal endothelial symptoms, disorders, or diseases; in particular, corneal endothelial symptoms, disorders, or diseases that are attributed to overexpression of the transforming growth factor-β (TGF-β) signal and/or extracellular matrix (ECM).

Find Patent Forward Citations

Koizumi, Noriko. (2022). Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof (U.S. Patent No. 11433090). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11433090

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…